Formed in 2025, Archerfish Precision Diagnostics was incepted from the strategic merger of two industry leaders: Angsana Molecular and Diagnostics Laboratory and Pathnova Laboratories.
Angsana is a pioneer in the field of molecular oncology in Asia, having introduced clinical Next-Generation Sequencing (NGS) early on. They have a strong track record of successful commercialisation and bringing clinical diagnostics tests to the market.
Pathnova specialises in the development and manufacturing of diagnostic products, including the creation of intellectual property related to novel diagnostic technologies, exemplified by their proprietary early screening test for nasopharyngeal cancer.
Recognising the immense potential for synergy, these two powerhouses joined forces, creating a unified entity with a clear vision: to address the specific healthcare needs of the Asian community.
Company Details
- Address
- 67 Ubi Avenue 1, Starhub Green North Wing, #06-06,singapore
- Industry
- Medical And Diagnostic Laboratories
- NAICS
-
Medical and Diagnostic LaboratoriesMedical LaboratoriesDiagnostic Imaging Centers
- Website
- http://www.archerfishdx.com
- HQ
- Singapore
Archerfish Precision Diagnostics Questions
Archerfish Precision Diagnostics's website is http://www.archerfishdx.com
Archerfish Precision Diagnostics's LinkedIn profile is https://sg.linkedin.com/company/archerfish-precision-diagnostics
Archerfish Precision Diagnostics's industry is
Medical and Diagnostic Laboratories
Archerfish Precision Diagnostics's top competitors are
Psv Laboratory,
Oriental Remedies Clinic 源自梁药,
Soma Haus Pte. Ltd,
Dermstetiq Clinic,
Flexfit Physiotherapy Pte Ltd,
Pathnova Laboratories,
Pioneer Associates,
Angsana Molecular & Diagnostic Laboratory Pte Ltd,
New Medical Laboratory,
Sam Laboratory.
Archerfish Precision Diagnostics's categories are Medical and Diagnostic Laboratories
